Ambiq Micro, Inc.
AMBQ NYSE Semiconductors & Related Devices Financials FY2024–FY2025
What Ambiq Micro, Inc. does
No business description yet.
- Legal name
- Ambiq Micro, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 5, 2026
- Accession · CIK
- 0001193125-26-094004
0001500412
Revenue and margins
Ambiq Micro, Inc. had $72.5M of revenue in fiscal 2025, down 4.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ambiq Micro, Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 2,036.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Ambiq Micro, Inc. can carry it.
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $61.0M | $140M |
| Current ratio | 7.6x | 8.8x |
| Quick ratio | 6.3x | 7.9x |
| Total assets | $104M | $185M |
| Total liabilities | $18.5M | $22.2M |
| Shareholders' equity | −$292M | $162M |
| Net debt (− = net cash) | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✕ |
| Return on assets rose | — | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | ✓ |
| Share count didn't rise | — | ✕ |
| Gross margin rose | — | ✓ |
| Revenue rose relative to assets | — | ✕ |
| F-score | — / 3 | 4 / 8 |
| Accruals ratio | −17.5% | −11.6% |
| Altman Z'' | −24.34 | 5.22 |
2 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | $76.1M | $72.5M |
| Gross profit | $24.3M | $32.1M |
| Research and development | $37.2M | $38.5M |
| Operating income | −$40.6M | −$39.5M |
| Pretax income | −$39.6M | −$36.4M |
| Income tax | $0.0M | $0.0M |
| Net income | −$39.7M | −$36.5M |
| Net income to common | −$42.4M | −$36.5M |
| Diluted EPS | −$113.50 | −$4.57 |
| Diluted shares | 0.00B | 0.01B |
| Cash flow | ||
| Cash from operations | −$21.4M | −$19.7M |
| Depreciation and amortization | $6.2M | $7.2M |
| Stock-based compensation | $5.2M | $6.8M |
| Balance sheet | ||
| Cash and short-term investments | $61.0M | $140M |
| Current assets | $89.0M | $168M |
| Current liabilities | $11.8M | $19.2M |
| Inventory | $15.0M | $16.9M |
| Property and equipment, net | $2.6M | $4.1M |
| Intangible assets | $11.7M | $11.6M |
| Total assets | $104M | $185M |
| Total liabilities | $18.5M | $22.2M |
| Shareholders' equity | −$292M | $162M |
| Margins | ||
| Gross margin | 31.9% | 44.3% |
| Operating margin | −53.4% | −54.5% |
| EBITDA margin | −45.2% | −44.6% |
| Net margin | −52.1% | −50.3% |
| Returns | ||
| Return on capital employed | −43.9% | −23.9% |
| Return on assets | −38.0% | −25.2% |
| Return on tangible equity | — | −24.2% |
| Growth | ||
| Revenue growth | — | −4.7% |
| Share count change | — | 2,036.4% |
| Financial health | ||
| Current ratio | 7.6x | 8.8x |
| Quick ratio | 6.3x | 7.9x |
| Capital allocation | ||
| Stock comp / revenue | 6.8% | 9.4% |
| Quality scores | ||
| Piotroski F-score | — | 4.0 |
| Altman Z'' | −24.3 | 5.2 |
| Accruals ratio | −17.5% | −11.6% |
Source: SEC EDGAR XBRL filings (CIK 0001500412). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.